Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Amdocs Limited. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is Amdocs Limited (DOX) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of shareholders of Amdocs Limited (NASDAQ: DOX).
On November 3, 2026, Amdocs issued a press release reporting its financial results for its fiscal fourth quarter and full year of 2026. Among other items, Amdocs forecast that its revenue growth would decline 14.3% to 17.9% and its earnings per share would decline 26% to 30% during its fiscal full year of 2027, citing a contractual dispute with T-Mobile, one of its largest customers, and the dispute’s potential impact on the Company’s future business. Following this news, Amdocs’s ordinary share price fell $18.77 per share, or 30.07%, to close at $43.66 per share on November 4, 2026.
What Potential Securities Violations Is BG&G Investigating?
- Whether Amdocs Limited and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
- Whether Amdocs Limited failed to disclose material adverse information that would have been significant to a reasonable investor.
- Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.
What Should Amdocs Limited (DOX) Investors Do?
How Is Amdocs Limited (NASDAQ: DOX) Stock Trading Today?
Interactive chart showing the weekly share price history of NASDAQ:DOX (NASDAQ:DOX).
How Does BG&G Help Investors in Securities Fraud Investigations?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”